首页> 美国卫生研究院文献>Lipids in Health and Disease >RESEARCH (Recognized effect of Statin and ezetimibe therapy for achieving LDL-C Goal) a randomized doctor-oriented multicenter trial to compare the effects of higher-dose statin versus ezetimibe-plus-statin on the serum LDL-C concentration of Japanese type-2 diabetes patients design and rationale
【2h】

RESEARCH (Recognized effect of Statin and ezetimibe therapy for achieving LDL-C Goal) a randomized doctor-oriented multicenter trial to compare the effects of higher-dose statin versus ezetimibe-plus-statin on the serum LDL-C concentration of Japanese type-2 diabetes patients design and rationale

机译:研究(Statin和ezetimibe疗法对实现LDL-C目标的公认作用)一项以医生为中心的随机多中心试验比较了大剂量他汀类药物与ezetimibe加他汀类药物对日本人血清LDL-C浓度的影响2型糖尿病患者的设计和基本原理

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AimsHypercholesterolemia coexisting with diabetes still requires clinical intervention to manage the high risk of cardiovascular disease it poses. No second-step strategy is established, however, for cases where strong statins fail to bring cholesterol down to target levels. In this study we seek to demonstrate the superior effect of ezetimibe in combination with strong statins to reduce LDL-C in Japanese patients suffering from both T2DM and hyper LDL-cholesterolemia.
机译:目的与糖尿病并存的高胆固醇血症仍需要临床干预以控制其引起的心血管疾病的高风险。但是,对于强效他汀类药物无法将胆固醇降至目标水平的情况,则没有第二步策略。在这项研究中,我们试图证明依泽替米贝与强效他汀类药物联合治疗在患有T2DM和高LDL-胆固醇血症的日本患者中降低LDL-C的优异效果。

著录项

相似文献

  • 外文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号